Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Spencer Marcantonio Camargo is active.

Publication


Featured researches published by Spencer Marcantonio Camargo.


Transplantation | 2010

Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.

Alessandro C. Pasqualotto; Melissa Orzechowski Xavier; Letícia Sanchez; Clarice Daniele Oliveira Costa; Sadi Marcelo Schio; Spencer Marcantonio Camargo; José de Jesus Peixoto Camargo; Teresa C. T. Sukiennik; Luiz Carlos Severo

Background. Galactomannan (GM) detection in serum samples has been used to diagnose invasive aspergillosis (IA). Limited sensitivity has been observed in lung transplant recipients, for whom bronchoalveolar lavage (BAL) testing has been advocated. Because airway colonization with Aspergillus species occurs frequently in these patients, false-positive GM results have been reported if the cutoff validated for sera is used (i.e., 0.5). Methods. Herein, we prospectively studied BAL fluid samples from 60 lung transplant patients to determine the optimal cutoff for BAL GM testing. Only one sample per patient was studied. BAL samples were vortexed and processed according to the manufacturers instructions for serum samples. Sensitivity, specificity, and likelihood ratios were calculated in reference to proven or probable IA cases using receiver operating characteristic analysis. Results. Eight patients had IA during the study (incidence 13.3%), including four patients with proven IA. Aspergillosis increased 5-fold the risk of death in lung transplant recipients. The positive predictive value of a positive BAL GM test at the 0.5 cutoff was low (24.2%). Raising the cutoff improved test specificity without compromising sensitivity. The best cutoff was defined at 1.5 (sensitivity 100% and specificity 90.4%). Conclusions. This study reinforces the importance of BAL GM testing in lung transplant recipients, particularly to exclude the diagnosis of IA. To minimize the frequency of false-positive results, a higher test cutoff should be applied to BAL samples, in comparison with serum samples.


Lung Cancer | 2010

Surgical treatment of bronchial carcinoid tumors: a single-center experience.

Tiago Noguchi Machuca; Paulo Francisco Guerreiro Cardoso; Spencer Marcantonio Camargo; Leonardo Signori; Cristiano Feijó Andrade; Ana Luiza Schneider Moreira; José da Silva Moreira; José Carlos Felicetti; José de Jesus Peixoto Camargo

BACKGROUND Bronchial carcinoid is an infrequent neoplasm with a neuroendocrine differentiation. Surgical treatment is the gold standard therapy, with procedures varying from sublobar resections to complex lung sparing broncoplastic procedures. This study evaluates the results of surgical treatment of bronchial carcinoids and its prognostic factors. PATIENTS AND METHODS Retrospective review of 126 consecutive patients who underwent surgical treatment for bronchial carcinoid tumors between December 1974 and July 2007. RESULTS There were 70 females (55%) and the mean age was 46 years, ranging from 17 to 81 years. Upon clinical presentation, 38 patients (30%) have had recurrent respiratory tract infection, 31 (24%) cough, 16 (12%) chest pain and 25 (20%) were asymptomatic. Preoperative bronchoscopic diagnosis was obtained in 74 cases (58.7%). The procedures performed were: 19 sublobar resections (14,9%), 58 lobectomies (46%), 8 bilobectomies (6.3%), 6 pneumonectomies (4.7%), 2 sleeve segmentectomies (1.5%), 26 sleeve lobectomies (20.6%) and 9 bronchoplastic procedures without lung resection (7.1%). Operative mortality was 1.5% (n = 2) and morbidity was 25.8% (n=32), including 12 respiratory tract infections and 4 reinterventions due to bleeding (3) and pleural empyema (1). Among the 112 patients available for follow-up, the overall survival at 3, 5 and 10 years was 89.2%, 85.5% and 79.8%, respectively. Five and 10-year survival for typical and atypical carcinoids were 91, 89% and 56, 47%, respectively. Overall disease-free survival at 5 years was 91.9% Statistical analysis showed that overall disease-free survival correlated with histology--typical vs. atypical--(p = 0.04) and stage (p = 0.02). CONCLUSION Surgery provides safe and adequate treatment to bronchial carcinoid tumors. Histology and stage were the main prognostic factors.


Transplantation | 2010

Acute humoral rejection in a lung recipient: reversion with bortezomib.

Jorge Neumann; Heloisa Tarrasconi; A. Bortolotto; Tiago Noguchi Machuca; Raquel Lisiane Canabarro; Heloísa Coutinho Sporleder; Sandra Fernandes; Sadi Marcelo Schio; Clarisse Costa; Spencer Marcantonio Camargo; Letícia Sanchez; José de Jesus Peixoto Camargo; Fabíola Adélia Perin; José Carlos Felicetti; Tatiana Michelon

on treatment, the poorly functioning area signifying the abscess cavity showed a reduction in size with alteration of shape and a decline in R2* value within, whereas T1-weighted and T2-weighted images showed only minimal changes (Fig. 1). Functional changes preceded morphologic changes as the abscess became gradually enclosed by normal functioning renal tissue. Prednisolone perhaps reduced the surrounding fibrosis as described by Haramaki et al. (4) No hypermetabolizing tissue was seen around the abscess as might be expected in a pyogenic abscess with surrounding inflammation. Using its ability to estimate tissue oxygen bioavailability, BOLD MRI can distinguish between acute rejection and acute tubular necrosis in a setting of early renal allograft dysfunction (5, 6). Although this technique cannot quantify absolute tissue oxygen levels because of the nonlinear relationship between R2* values and the partial pressure of oxygen, it could be used in various clinical situations to monitor renal oxygenation. This is the first report of the use of BOLD MRI to demonstrate the functional changes associated with a healing tuberculous abscess in a renal allograft. More studies may be required to obtain any further conclusion. This ability to combine functional with morphologic imaging heralds a new horizon and could emerge as a useful tool for vascular and functional assessment of the kidneys.


Jornal Brasileiro De Pneumologia | 2008

Complicações relacionadas à lobectomia em doadores de transplante pulmonar intervivos

Spencer Marcantonio Camargo; José de Jesus Peixoto Camargo; Sadi Marcelo Schio; Letícia Sanchez; José Carlos Felicetti; José da Silva Moreira; Cristiano Feijó Andrade

OBJECTIVE To evaluate post-operative complications in living lobar lung transplant donors. METHODS Between September of 1999 and May of 2005, lobectomies were performed in 32 healthy lung transplant donors for 16 recipients. The medical charts of these donors were retrospectively analyzed in order to determine the incidence of postoperative complications and alterations in pulmonary function after lobectomy. RESULTS Twenty-two donors (68.75%) presented no complications. Among the 10 donors presenting complications, the most frequently observed complication was pleural effusion, which occurred in 5 donors (15.6% of the sample). Red blood cell transfusion was necessary in 3 donors (9.3%), and 2 donors underwent a second surgical procedure due to hemothorax. One donor presented pneumothorax after chest tube removal, and one developed respiratory infection. There were two intra-operative complications (6.25%): one donor required bronchoplasty of the middle lobe; and another required lingular resection. No intra-operative mortality was observed. Post-operative pulmonary function tests demonstrated an average reduction of 20% in forced expiratory volume in one second (p < 000.1) compared to pre-operative values. CONCLUSIONS Lobectomy in living lung transplant donors presents high risk of post-operative complications and irreversible impairment of pulmonary function. Careful pre-operative evaluation is necessary in order to reduce the incidence of complications in living lobar lung transplant donors.


European Journal of Cardio-Thoracic Surgery | 2010

Surgical treatment of benign tracheo-oesophageal fistulas with tracheal resection and oesophageal primary closure: is the muscle flap really necessary? §

José de Jesus Peixoto Camargo; Tiago Noguchi Machuca; Spencer Marcantonio Camargo; Vivalde Lobato; Carlos Remolina Medina

OBJECTIVES Nowadays, despite the advances of the low-pressure high-volume cuffs, post-intubation tracheo-oesophageal fistula (TEF) still poses a major challenge to thoracic surgeons. The original technique includes interposition of muscle flaps between suture lines to avoid recurrence. It is not clear if this manoeuvre is indispensable and, in fact, we and others have faced problems with it. Our aim is to present our experience with TEF management in a consecutive group with no muscle interposition. METHODS From June 1992 to November 2007, we evaluated 14 patients presenting with TEF, with a mean age of 44 years (from 18 to 79 years). Thirteen patients had a prolonged intubation history. The remaining case was a 40-year-old male with congenital TEF. Three patients had been previously submitted to failed repairs in other institutions. Ten patients had associated tracheal stenosis, which was subglottic in three of them. Regarding surgical technique, in all cases, we performed a single-staged procedure, which consisted of tracheal resection and anastomosis with double-layer oesophageal closure. In none of our cases was a muscle flap interposed between suture lines. RESULTS All operations were performed through a cervical incision; however, in one case, an extension with partial sternotomy was required. There was no operative mortality. Thirteen patients were extubated in the first 24h after the procedure, while one patient required 48 h of mechanical ventilation. Four complications were recorded: one each of pneumonia and left vocal cord paralysis and two small tracheal dehiscences managed with a T-tube and a tracheostomy tube. After discharge, three patients returned to their native cities and were lost to follow-up. The remaining 11 patients have been followed up by a mean of 32 months (from three to 108 months), with 10 presenting excellent and one good anatomic and functional results. CONCLUSIONS The single-staged repair with tracheal resection and anastomosis with oesophageal closure provides good short- and mid-term results for TEF management. The interposition of a muscle flap between suture lines may not be crucial to prevent recurrence.


The Annals of Thoracic Surgery | 2003

Nonfunctioning paraganglioma of the aortopulmonary window

Cristiano Feijó Andrade; Spencer Marcantonio Camargo; Marcelo Zanchet; José Carlos Felicetti; Paulo Francisco Guerreiro Cardoso

Aortopulmonary paraganglioma is a rare tumor of the mediastinum. The only effective treatment is complete resection, which may pose a surgical challenge because of its proximity to the heart, great vessels, and trachea, often rendering a complete resection difficult to achieve. We report a case in which the tumor was excised under cardiopulmonary bypass and resulted in massive bleeding only controlled by means of packing the pleural cavity during 48 hours, known as damage control strategy. The patient survived and has been disease-free for 2 years.


Transplantation | 2011

Prognostic Factors in Lung Transplantation: The Santa Casa de Porto Alegre Experience

Tiago Noguchi Machuca; Sadi Marcelo Schio; Spencer Marcantonio Camargo; Vivalde Lobato; Clarice Daniele Oliveira Costa; José Carlos Felicetti; José da Silva Moreira; José de Jesus Peixoto Camargo

Background. Lung transplantation (LT) has been established as a current therapy for selected patients with end-stage lung disease. Different prognostic factors have been reported by transplant centers. The objective of this study is to report our recent results with LT and to search for prognostic factors. Methods. We performed a retrospective analysis of 130 patients who underwent LT at our institution from January 2004 to July 2009. Donor, recipient, intraoperative, and postoperative variables were collected. Results. The mean age was 53.14 years (ranging from 8 to 72 years) and 80 (61.5%) were male. The main causes of end-stage respiratory disease were pulmonary fibrosis 53 (40.7%) and chronic obstructive pulmonary disease 52 (40%). The actuarial 1-year survival was 67.7%. Variables correlated with survival were age (P=0.004), distance in the 6-min walk test (P=0.007), coronary heart disease (P=0.001), cardiopulmonary bypass (P=0.02), intraoperative transfusion of red blood cells (P=0.016), increasing central venous pressure at 24th postoperative hour (P=0.001), increasing pulmonary capillary wedge pressure at 24th postoperative hour (P=0.01); length of intubation (P<0.01), reintubation (P=0.001), length of intensive care unit stay (P<0.001), abdominal complication (P=0.003), acute renal failure requiring dialysis (P<0.001), native lung hyperinflation (P=0.02), and acute rejection in the first month (P=0.03). In multivariate analysis, only dialysis (P=0.004, hazards ratio [HR] 2.68), length of intubation (P=0.004, HR 1.002 for each hour), and reintubation (P=0.003, HR 2.88) proved to be independent predictors. Conclusion. Analysis of variables in our cohort highlighted dialysis, longer mechanical ventilation requirement, and reintubation as independent prognostic factors in LT.


Journal of Thoracic Imaging | 2010

Large pulmonary artery pseudoaneurysm due to lung carcinoma: pulmonary artery pseudoaneurysm.

José de Jesus Camargo; Spencer Marcantonio Camargo; Tiago Noguchi Machuca; Rodrigo Moreira Bello

We present the case of a 54-year-old patient who presented to our institution 4 months after refusing surgical treatment for a right upper lobe cavitary carcinoma. Weight loss, hemoptysis, and worsening pulsatile chest pain were the complaints. Radiologic restaging surprisingly revealed a large pulmonary artery pseudoaneurysm occupying the whole cavity area. A right pneumonectomy with intrapericardial pulmonary artery ligation was performed. Previous cases are extremely rare and differ from ours as patients presented with advanced lung cancer and thus, were not treated with resection, but with coil embolization.


European Journal of Cardio-Thoracic Surgery | 2008

Surgical maneuvers for the management of bronchial complications in lung transplantation

José de Jesus Peixoto Camargo; Spencer Marcantonio Camargo; Tiago Noguchi Machuca; Fabíola Adélia Perin; Sadi Marcelo Schio; José Carlos Felicetti

BACKGROUND Many advances have substantially improved the clinical results of lung transplantation. However, the incidence of bronchial complications is still high, with significant impact on survival and limited interventional strategies for complex cases. Our aim is to evaluate the surgical management of bronchial complications following lung transplantation. METHODS From May 1989 to June 2007, 251 patients were submitted to lung transplantation at our institution. In five cases, the bronchial complications observed were dealt with open surgical procedures. RESULTS Complications surgically dealt were one broncho-arterial fistula and four stenosis. One left upper sleeve lobectomy, one right upper sleeve lobectomy and three segmental bronchial resections with anastomosis were performed. In all five cases the surgical procedure was successful and optimal bronchial healing was observed. Three patients died due to causes unrelated to the bronchial anastomosis 5, 21 and 32 months after the bronchoplastic procedure. Two patients are still alive and functionally well at 52 and 70 months post-bronchoplasty. CONCLUSIONS Surgical management of bronchial complications after lung transplantation may be the last resort in complex, recalcitrant cases, nevertheless it is a feasible procedure and can provide good results not only on short- but also long-term follow-up.


Revista Brasileira De Terapia Intensiva | 2016

Diretrizes para avaliação e validação do potencial doador de órgãos em morte encefálica

Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine V Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antonio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala; Anderson Gonçalves; Lúcio Filgueiras Pacheco-Moreira; Fernando Suparregui Dias; Rogério Fernandes; Frederico Di Giovanni; Frederico Bruzzi de Carvalho; Alfredo Fiorelli; Cassiano Teixeira; Cristiano Feijó; Spencer Marcantonio Camargo; Neymar Elias de Oliveira

O transplante de orgaos e a unica alternativa para muitos pacientes portadores de algumas doencas terminais. Ao mesmo tempo, e preocupante a crescente desproporcao entre a alta demanda por transplantes de orgaos e o baixo indice de transplantes efetivados. Dentre as diferentes causas que alimentam essa desproporcao, estao os equivocos na identificacao do potencial doador de orgaos e as contraindicacoes mal atribuidas pela equipe assistente. Assim, o presente documento pretende fornecer subsidios a equipe multiprofissional da terapia intensiva para o reconhecimento, a avaliacao e a validacao do potencial doador de orgaos.Organ transplantation is the only alternative for many patients with terminal diseases. The increasing disproportion between the high demand for organ transplants and the low rate of transplants actually performed is worrisome. Some of the causes of this disproportion are errors in the identification of potential organ donors and in the determination of contraindications by the attending staff. Therefore, the aim of the present document is to provide guidelines for intensive care multi-professional staffs for the recognition, assessment and acceptance of potential organ donors.

Collaboration


Dive into the Spencer Marcantonio Camargo's collaboration.

Top Co-Authors

Avatar

José de Jesus Peixoto Camargo

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

José Carlos Felicetti

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Hochhegger

Universidade Federal de Ciências da Saúde de Porto Alegre

View shared research outputs
Top Co-Authors

Avatar

Edson Marchiori

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

José da Silva Moreira

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Maria Teresa Ruiz Tsukazan

Pontifícia Universidade Católica do Rio Grande do Sul

View shared research outputs
Researchain Logo
Decentralizing Knowledge